金币
UID176556
帖子
主题
积分25076
注册时间2014-6-6
最后登录1970-1-1
听众
性别保密
|
发表于 2017-10-7 13:47:36
|
显示全部楼层
合不合格和做不作为返工以及重新加工没有直接关系,判定不合格是合理的做法,至于退货你自己是否返工是基于你的判定,但是一个关注点就是需要确保运输途中的破损的原因是否可能存在人为故意或掺杂以及是否遭受极端的环境的风险。最好进一步操作前应核实相应的运输监控等数据,外观全面核查以及全面质量检测。这个关于药品抢救的问题(product salvage)唯独在FDA CGMP part 11 §211.208中有相关的说明,可以参考!
Drug product salvaging.
Drug products that have been subjected to improper storage conditions including extremes in temperature, humidity, smoke, fumes, pressure, age, or radiation due to natural disasters, fires, accidents, or equipment failures shall not be salvaged and returned to the marketplace. Whenever there is a question whether drug products have been subjected to such conditions, salvaging operations may be conducted only if there is (a) evidence from laboratory tests and assays (including animal feeding studies where applicable) that the drug products meet all applicable standards of identity, strength, quality, and purity and (b) evidence from inspection of the premises that the drug products and their associated packaging were not subjected to improper storage conditions as a result of the disaster or accident. Organoleptic examinations shall be acceptable only as supplemental evidence that the drug products meet appropriate standards of identity, strength, quality, and purity. Records including name, lot number, and disposition shall be maintained for drug products subject to this section.
其实早期1998年的FDA GFI Manufacturing, Processing, or Holding Active Pharmaceutical Ingredients也有提及,但是这个指南被ICH的Q7取代了,并且在Q7中也未提及API以及intermediates salvaging的问题,不知道是什么原因??
salvage是仅仅指不经过处理重新返回市场销售吗??
salvage是仅仅针对于制剂,不针对于原料药吗??原料要出现这种情况如何处理呢??
salvage为什么除了FDA提及,在其他GMP中均未提及呢????
@叶非
|
|